Related Experiment Videos
Matrix metalloproteinases: implication in vascular matrix remodelling during atherogenesis
1Department of Cardiovascular Medicine, University of Oxford, U.K.
Clinical Science (London, England : 1979)
|April 16, 1998
Summary
A genetic variant in the stromelysin gene promoter (6A allele) is linked to increased atherosclerosis progression. This variant may exacerbate matrix deposition in coronary artery disease patients, impacting plaque development.
Area of Science:
- Biochemistry
- Genetics
- Cardiovascular Medicine
Background:
- Matrix metalloproteinases (MMPs) are enzymes involved in extracellular matrix remodeling.
- Atherosclerosis pathogenesis involves vascular matrix remodeling, with some MMPs implicated.
- A common genetic variant in the stromelysin gene promoter exists with 5A and 6A alleles.
Purpose of the Study:
- To investigate the functional consequences of the stromelysin gene promoter variant.
- To determine the association between the stromelysin gene promoter variant and coronary artery disease progression.
Main Methods:
- Functional analysis of stromelysin promoter activity for 5A and 6A alleles.
- Quantitative angiography to assess atherosclerosis progression in patients with coronary artery disease.
Main Results:
- The 6A allele exhibits lower promoter activity than the 5A allele due to repressor protein binding.
- The 6A allele is associated with accelerated atherosclerosis progression in patients with coronary artery disease.
- Lower stromelysin expression in 6A6A genotype individuals may favor matrix deposition.
Conclusions:
- Matrix metalloproteinases may contribute to plaque rupture in specific atherosclerotic areas.
- Imbalance favoring matrix deposition is characteristic of atheromas.
- Individuals with the 6A6A genotype may experience exacerbated matrix deposition due to reduced stromelysin expression.